Kinase Inhibitors (Otsuka Pharmaceutical)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameKinase Inhibitors (Otsuka Pharmaceutical)
Drug Alias NameKinase Inhibitors (Mirati/Otsuka Pharmaceutical)Kinase Inhibitors (MethylGene/Otsuka Pharmaceutical)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein kinases inhibitors
TargetsProtein kinases
Therapy Area/IndicationsEye Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMethylgene Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMirati Therapeutics IncMethylgene IncOtsuka Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsEye Diseases

Other Information

ATC CodeN/A
Related LinksN/A